| Net income (loss) | 37.39M |
| Depreciation of property, plant and equipment | 117.69M |
| Amortization of definite-lived intangible assets | 17.85M |
| Amortization of convertible notes, debt discount and debt issuance costs | 16.4M |
| Non-cash interest imputed on other long-term liabilities and related party financing obligation | |
| Income tax benefit from restricted stock units released and common stock options exercised | |
| Deferred income taxes | |
| Stock-based compensation | 7.89M |
| Impairment of long-lived assets | |
| Realized gain on early payment of related party financing obligation | |
| Net loss on sale of property, plant and equipment and other | |
| Net unrealized loss on derivative assets and liabilities | |
| Net realized foreign currency exchange loss | |
| Accounts and notes receivable, net | 6.08M |
| Inventories | -12.25M |
| Prepaid expenses and other current assets | 3.13M |
| Accounts payable | |
| Accrued salaries, wages and benefits and other accrued expenses | -6.04M |
| Net cash provided by operating activities | |
| Purchase of property, plant and equipment and equipment deposits | -62.52M |
| Proceeds from sale of property, plant and equipment and assets held for sale | |
| Acquisition, net of cash acquired | 0 |
| Restricted cash used for acquisition | |
| Proceeds from the redemption of short-term investments | |
| Net cash (used in) provided by investing activities | |
| Proceeds from revolving loan | |
| Repayment of long-term borrowings | -106.48M |
| Proceeds from long-term borrowings | 0 |
| Repayment of assumed long-term debt in acquisition | 0 |
| Settlement of related party financing obligation | |
| Proceeds from exercise of stock options | 123K |
| Excess tax benefits from stock awards exercised or released | |
| Net cash (used in) provided by financing activities | |
| Effect of foreign currency exchange rates on cash and cash equivalents | -4.18M |
| Net increase in cash and cash equivalents | 32.68M |
| Cash and cash equivalents at beginning of period | 259.1M |
| Cash and cash equivalents at end of period | 291.78M |
| Accrued purchases of Equipment | 21.06M |
| Issuance of Common stock and replacement award at fair value | |